Metabolic Solutions (MetSol) is a bio-analytical laboratory based in Nashua, New Hampshire that uses mass spectrometry equipment for specialized medical testing and metabolic pre-clinical and clinical studies. Metabolic Solutions is a market leader in the stable isotope measurement technique niche, and clients include some of the most influential biotech and pharma companies in the world. The work MetSol has been involved in has helped diagnose patients with rare gastro diseases and has also supported new drug discoveries that are at the forefront of science, particularly in rare disease, gene therapy, obesity, and liver disease.
The company was acquired via a search fund investment vehicle in the Spring of 2024, led by current CEO Adnan Fakhoury (HBS’22), and is currently undergoing several initiatives aimed at growing and professionalizing the business.